Most people with COVID-19 will test positive on a rapid antigen test for roughly five to twelve days after symptoms start, though PCR tests can pick up viral genetic material for considerably longer, sometimes three weeks or more. The difference comes down to what each test detects and how much virus your body is still producing. Peak viral loads tend to hit around day four or five of symptoms, and from there the trajectory varies depending on your immune status, disease severity, and the type of test you are using.
When Your Viral Load Peaks
After you become infected with SARS-CoV-2, the virus replicates rapidly in your upper airway. Studies tracking viral loads in symptomatic people have consistently found that the amount of virus in nasal swabs climbs during the first few days of illness and peaks around day four to five after symptom onset.1PubMed Central. The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs A large review of shedding kinetics confirmed this pattern, noting that RNA viral loads peak early in the symptomatic period and then gradually decline, reaching low or undetectable levels roughly two weeks after symptoms begin.2Nature Reviews Microbiology. SARS-CoV-2 viral load and shedding kinetics
This peak matters because it is the window when both PCR and rapid antigen tests are most sensitive. Testing too early, within the first day or two of symptoms or before symptoms appear, can miss the infection simply because there is not yet enough virus to detect. Testing on day three through five generally gives you the most reliable result.
How Long PCR Tests Stay Positive
PCR (also called RT-PCR or molecular tests) works by amplifying tiny fragments of viral RNA, making it extraordinarily sensitive. That sensitivity is a double-edged sword: it catches infections very early but also picks up leftover RNA fragments long after you have stopped being contagious. A systematic review of individual patient data found that nasopharyngeal PCR detected virus in about 89% of people during the first zero to four days after symptom onset, dropping to roughly 54% by days ten through fourteen.3PubMed Central. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data A separate hospital-based study showed PCR sensitivity above 90% in the first five days, falling to about 70% between days nine and eleven, and around 30% by day twenty-one.4PubMed Central. Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital
In some people, however, PCR stays positive far longer. The systematic review noted that a few participants still had detectable virus at 46 days after symptoms started.3PubMed Central. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data This does not mean those people were still infectious. PCR amplifies even non-viable, fragmented RNA, so a positive result weeks after infection often reflects molecular debris rather than live virus. This is why many guidelines moved away from requiring a negative PCR to end isolation and shifted toward antigen-based approaches or time-based criteria instead.
How Long Rapid Antigen Tests Stay Positive
Rapid antigen tests detect viral proteins rather than genetic material, so they require a higher amount of virus to trigger a positive line. For most people with a mild or moderate case, rapid tests flip positive around the time symptoms appear, stay positive for roughly a week, and turn negative within about ten to twelve days. But there are outliers. A case series documented four patients with mild COVID-19 whose rapid antigen tests remained continuously positive for 23, 25, 27, and 30 days respectively, well after they had recovered clinically and were asymptomatic.5PubMed Central. Prolonged rapid antigen test positivity among COVID-19 patients
Those extended positives are uncommon, but they illustrate a frustrating reality: there is no single cutoff that applies to everyone. Your body’s ability to clear the virus, the amount of virus your cells initially produced, and your immune response all influence how quickly antigen levels fall below the test’s detection threshold.
Testing Positive Versus Being Contagious
A positive test does not automatically mean you are still spreading the virus. Live, replication-competent virus (the kind that infects other people) disappears from the upper airway faster than the molecular traces that tests detect. A study in England found that the probability of growing live virus from a sample dropped to about 6% once someone was ten or more days past symptom onset.6PubMed Central. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 The same study showed that samples with high PCR cycle threshold values, meaning very low amounts of viral RNA, almost never yielded live virus.
Rapid antigen tests, by their nature, correlate better with contagiousness than PCR does. Research comparing antigen results directly with viral culture found strong agreement between a positive antigen test and the ability to grow live virus, suggesting that if your rapid test is still positive, you are more likely to still be shedding infectious virus.7PubMed Central. The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19 Another study evaluating a rapid antigen test against viral culture found that when the antigen test was negative, the negative predictive value for culture was 100%, meaning none of the antigen-negative samples contained live virus.8PubMed Central. The evaluation of a rapid microfluidic immunofluorescence antigen test in detecting the infectiousness of COVID-19 patients In practical terms, a negative rapid test is a reasonably good signal that you are no longer a threat to others, even if a PCR taken the same day might still come back positive.
Why Severe Illness Extends Positivity
People who develop severe or critical COVID-19 tend to shed virus, including live virus, for longer than those with mild illness. In hospitalized patients with severe disease, researchers were able to culture infectious virus well beyond eight days from symptom onset, and in one patient, up to 20 days.9Nature Communications. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) By contrast, earlier studies of mild cases had found that live virus generally could not be isolated after about eight days. A separate analysis confirmed that while initial viral shedding in the first week was similar between severe and mild cases, by the second week the viral load remained elevated in severely ill patients.10PubMed. Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients
Higher viral loads in severe cases are part of the explanation, but the immune response also plays a role. A healthy immune system begins clearing the virus aggressively within the first week, while a body overwhelmed by the infection struggles to keep pace. This is why many hospitals used longer isolation windows for critically ill patients and why the blanket “five days of isolation” guidance was always a simplification.
Immunocompromised People and Prolonged Shedding
The starkest outliers in testing duration are people with weakened immune systems. A case report described a 62-year-old immunosuppressed man who tested positive for over 230 days, the longest documented case of symptomatic COVID-19 at the time of publication.11PubMed Central. Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States Research on three severely immunocompromised patients showed they were shedding infectious (culturable) virus for up to four months after symptoms began, with one patient having a positive viral culture 123 days into their infection.12The Journal of Infectious Diseases. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection
These are not just positive PCR results picking up dead RNA. These patients were producing live virus capable of infecting cells in culture, meaning they remained genuinely contagious for months. This group includes people on immunosuppressive medications for organ transplants, those undergoing chemotherapy, and people with advanced HIV or certain blood cancers. If you fall into one of these categories and test positive, the usual timelines simply do not apply. Infectious disease specialists often recommend serial testing and longer isolation periods for this population.
Does Vaccination Shorten How Long You Test Positive?
Vaccination appears to speed up viral clearance, though the effect depends on the variant. A study of over 1,400 patients found that those who had received two or three vaccine doses converted to a negative test roughly a day faster than less-vaccinated individuals (about 6.3 days versus 7.4 days on average).13PubMed Central. Factors Influencing COVID-19 Viral Clearance: Implications for Vaccination and Antiviral Therapy Research on the Alpha and Delta waves showed that vaccinated people had shorter durations of positivity and lower viral loads compared to unvaccinated individuals, along with milder symptoms. However, the same study found that vaccination had no measurable impact on viral load, duration of positivity, or self-reported disease severity for infections caused by Omicron.14PubMed. The impact of vaccination and SARS-CoV-2 variants on the virological response to SARS-CoV-2 infections during the Alpha, Delta, and Omicron waves in England
The takeaway is that vaccination still helps, particularly by reducing severe illness, which in turn shortens the window of high viral shedding. But if you are dealing with current circulating variants (descended from Omicron), do not count on your vaccine status alone to predict when you will test negative.
Variant Differences Are Smaller Than You Might Think
There was widespread speculation that Omicron, being milder for most people, would also be cleared faster. The data tells a more nuanced story. A longitudinal study comparing Delta and Omicron found no significant differences in time to viral culture conversion between the two variants, even when stratified by booster status.15PubMed Central. Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study A separate study looking at long-term outcomes across Alpha, Delta, and Omicron also found no significant differences in viral persistence between variants.16PubMed Central. COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants The virus variant matters less than individual factors like immune status and disease severity when it comes to how long you keep testing positive.
Paxlovid Rebound and Re-Positivity
If you have taken the antiviral Paxlovid (nirmatrelvir/ritonavir), there is a well-documented phenomenon where symptoms and positive test results return a few days after finishing the five-day course. This rebound typically happens between five and eight days after stopping the medication.17PubMed Central. Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir The exact mechanism is not settled. Possibilities include the drug suppressing the virus without fully eliminating it, the immune system not generating a strong enough response while the drug is doing the work, or lingering high viral loads in people who appeared symptom-free.
Rebound complicates the testing timeline because you may test negative on day seven or eight, think you are in the clear, and then test positive again on day ten or twelve. If you took Paxlovid and your symptoms return, testing again is worthwhile. The rebound phase appears to be a genuine return of viral replication, not just residual RNA, so treating it as a period of potential infectiousness makes sense.
Testing From Different Body Sites
Where you swab matters more than people realize. A head-to-head study of nasal versus saliva rapid antigen tests found that nasal swabs caught about 69% of infections while saliva-based tests caught only about 47%.18PubMed Central. Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study When the comparison was restricted to samples with higher viral loads (a proxy for being infectious), nasal sensitivity rose to about 84% while saliva improved to only about 55%. If you are using a rapid test to decide whether you are still contagious, a nasal swab gives you a more reliable answer than a throat or saliva sample.
There is also an anecdotal pattern that many people noticed during the Omicron wave: throat swabs sometimes turned positive a day or two before nasal swabs. That observation has some biological logic, as different variants may preferentially infect different parts of the airway. But most at-home tests are validated for nasal use, and the available head-to-head data supports nasal sampling as the more sensitive approach for the antigen tests people actually have at home.
Fecal Shedding Lasts Far Longer Than Respiratory Shedding
Even after your nose swab comes back clean, SARS-CoV-2 RNA can linger in your gastrointestinal tract. A study tracking participants over months found that while no one was shedding viral RNA from the throat at four months, about 13% were still shedding it in stool. By seven months, roughly 4% still had detectable fecal shedding.19PubMed Central. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection This does not mean those people were contagious in the usual sense, since COVID-19 spreads overwhelmingly through respiratory droplets and aerosols. But it does suggest the virus can maintain a foothold in the gut long after the respiratory infection resolves.
This matters for a couple of practical reasons. Wastewater surveillance programs, which monitor COVID-19 levels in sewage to track community spread, pick up this prolonged fecal shedding. It is one reason wastewater data sometimes tells a different story than clinical testing numbers. And for people experiencing lingering GI symptoms after COVID-19, persistent gut infection is one hypothesis researchers are actively investigating.
Viral Persistence in Tissues and Long COVID
Beyond what shows up on a nasal swab or even a stool test, research has found that SARS-CoV-2 RNA and protein can persist in body tissues for months. An autopsy study identified viral RNA in dozens of tissue types, including lymph nodes, nerves, and multiple brain regions, collected up to 230 days after symptom onset. In one individual who died 230 days after a mild case, viral RNA was found in multiple anatomical sites, including several parts of the brain. Markers suggesting ongoing viral replication were identified in tissues as late as day 99.20Nature Immunology. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) This tissue persistence occurred even in people who had negative standard nasal PCR tests, meaning the virus can hide in places that routine testing never reaches.
This persistent viral reservoir is one of the leading hypotheses for why some people develop long COVID. The idea is that virus or viral fragments lurking in tissues drive ongoing inflammation and immune activation, contributing to symptoms like fatigue, brain fog, and cardiovascular problems.21PubMed Central. Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID None of this tissue persistence would show up on a home rapid test or even a standard clinical PCR. It represents a fundamentally different question from “when will I test negative?” but it is important context for understanding that the virus’s relationship with the body does not end the moment your nasal swab turns negative.
When a New Positive Test Means Reinfection, Not Lingering Virus
If you test positive again weeks or months after a previous infection, the question becomes whether this is leftover RNA from the first infection or a brand-new one. The general guideline for distinguishing the two is timing: a new positive detection more than 90 days after an initial infection, with or without symptoms, raises the possibility of genuine reinfection rather than persistent shedding. Between 45 and 89 days, reinfection is considered when there are new COVID-like symptoms and evidence of contact with a confirmed case.22PubMed Central. Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review
In practice, the distinction matters because prolonged RNA shedding from a resolved infection does not mean you are sick again or contagious. Researchers use genomic sequencing to settle ambiguous cases, comparing whether the later virus is genetically descended from the earlier one (persistent shedding) or belongs to a different lineage (reinfection).23Clinical Infectious Diseases. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study Most people will never need genomic sequencing to answer this question. But if you test positive a couple of months after a previous infection and are unsure what it means, the timing and symptom picture are your best practical guides.
Practical Guidance for Using Tests to End Isolation
Given everything above, using a rapid antigen test to decide when you are safe to be around others is more useful than a PCR for this purpose. A cost-effectiveness analysis modeling different de-isolation strategies found that the most efficient approach was performing an antigen test on day six of a ten-day isolation period.24PubMed Central. COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis Antigen testing on day five was also a reasonable option but led to slightly more secondary infections. PCR testing on day five was actually outperformed by the antigen approach because PCR’s residual positivity led to unnecessarily long isolation for some and false confidence for others.
A study comparing 18 different rapid antigen tests found that when tests were performed every two days combined with isolation at symptom onset, transmission was reduced by roughly 78%, outperforming PCR with a 24-hour result delay.25Communications Medicine. Comparative analyses of eighteen rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation The speed of rapid tests, giving a result in 15 minutes rather than a day, offset their lower sensitivity. For kids, the picture is similar: one study found that PCR cycle threshold values and antigen test performance were comparable between children and adults, and every pediatric sample that grew live virus in culture also had a positive antigen test.26PubMed Central. Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing Site
The simplest approach, if you are trying to figure out when you are no longer a risk to others: use a nasal rapid antigen test starting around day five or six of symptoms. If it is negative, you are very likely no longer shedding infectious virus. If it is still positive, wait a day and test again. Two consecutive negative rapid tests, taken 48 hours apart, give you strong confidence. A lingering positive PCR weeks later, by contrast, usually means nothing for the people around you.